Trials / Withdrawn
WithdrawnNCT06707038
Improving Access to Renal Transplantation for Underserved Black Communities
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn whether the African American Transplant Access Program can be successfully replicated at another large kidney transplant program. The main questions it aims to answer are: Does the AATAP intervention increase the number of Black patients who are listed for kidney transplant? Does the AATAP intervention have an effect on Black patient self-efficacy and trust in care team? Researchers will compare kidney transplant listing status after 12 months of patients in the AATAP intervention to usual care patients to see if the AATAP program increases the number of patients listed for transplant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | AATAP intervention | AATAP is a program created to address the barriers that Black patients face when accessing transplantation. AATAP providers resources in cultural congruency, trust, psychosocial support, and health literacy to provide patients with the individualized support needed to access the kidney transplant waitlist |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2025-05-06
- Completion
- 2025-05-06
- First posted
- 2024-11-27
- Last updated
- 2025-05-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06707038. Inclusion in this directory is not an endorsement.